Accordingly, the mice intraperitoneally injected with Rap1A shRNA expressing cells had a reduced metastasis tumor by at least one order of magnitude (Fig. 4M, N, O) and with a higher weight than control mice (Fig. 4P). Here, RAP1A is linked to neoplasm.